Want to join the conversation?
$BIIB made significant progress on capital allocation in 3Q15. The savings from corporate restructuring will be reinvested in key commercial initiatives. Progress has been made with several early stage programs; BIIB061 has successfully completed Phase I study.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?